Home
Conditions
Ovarian Neoplasms

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,291 public trials 504 recruiting studies

Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas

NCT00750386

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: University Hospital of Crete Heraklion, Crete, Greece

University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece

"IASO" General Hospital of Athnes, Dep of Medical Oncology Athens, Greece

"Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece

View Trial Details

Completed

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

NCT00270166

Conditions: Adnexal Diseases, Anemia, Blood Protein Disorders, +59 more
Locations: Not specified

View Trial Details

Completed

Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy

NCT00216645

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

NCT00667641

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +67 more
Locations: Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Completed

Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma

NCT00193297

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00028912

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

NCT00005049

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +39 more
Locations: NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States

View Trial Details

Completed

Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00006391

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States

View Trial Details

Completed

Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer

NCT00004083

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations: Kaplan Cancer Center New York, United States

View Trial Details

Completed

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer

NCT00003297

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations: Vincent T. Lombardi Cancer Research Center, Georgetown University Washington D.C., District of Columbia, United States

View Trial Details

Ovarian Neoplasms

Ovarian Neoplasms trial results

Related conditions